{"doi":"10.1038/ncprheum0465","title":"Imatinib for the treatment of rheumatic diseases","abstract":null,"journal":"Nature Clinical Practice Rheumatology","year":2007,"id":681384,"datarank":0.5050943744979712,"base_score":3.367295829986474,"endowment":3.367295829986474,"self_citation_contribution":0.5050943744979712,"citation_network_contribution":0.0,"self_endowment_contribution":0.5050943744979712,"citer_contribution":0.0,"corpus_percentile":null,"corpus_rank":null,"citation_count":28,"citer_count":0,"citers_with_citation_signal":0,"citers_with_endowment":0,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":null,"is_data_producer":false,"deposit_databanks":null,"is_oa":false,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":null,"fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":1780255,"name":"William H Robinson","orcid":null,"position":1,"is_corresponding":false},{"id":1780253,"name":"Ricardo T Paniagua","orcid":null,"position":0,"is_corresponding":false}],"reference_count":0,"raw_metadata":{"has_enrichment":true,"resolved":true,"title":"Imatinib for the treatment of rheumatic diseases","abstract":null,"is_dataset_classified":null,"base_score":3.367295829986474,"endowment":3.367295829986474,"datacite_reuse_total":0,"file_count":0,"downloads":0,"views":0,"has_version_chain":false,"is_dataset":false,"is_oa":false,"pmid":"17396105","pmcid":null,"openalex_id":"https://openalex.org/W2037178677","authors":[],"funders":[{"funder_name":"NIAID NIH HHS","grant_id":"T32 AI007290","title":null}],"total_grants":1,"fwci":2.4121,"citation_percentile":0.88812521,"influential_citations":0,"citation_trend":[{"year":2012,"count":2},{"year":2014,"count":1},{"year":2015,"count":1},{"year":2017,"count":1},{"year":2018,"count":1},{"year":2020,"count":1},{"year":2021,"count":3},{"year":2024,"count":1}],"oa_status":"closed","license":"http://www.springer.com/tdm","oa_locations":[{"url":"http://www.nature.com/articles/ncprheum0465.pdf","host_type":"publisher"},{"url":"http://www.nature.com/articles/ncprheum0465","host_type":"publisher"},{"url":"https://doi.org/10.1038/ncprheum0465","host_type":"journal"},{"url":"https://pubmed.ncbi.nlm.nih.gov/17396105","host_type":"repository"}],"fields_of_study":["Chronic Myeloid Leukemia Treatments","Chronic Lymphocytic Leukemia Research","Eosinophilic Disorders and Syndromes"],"mesh_terms":["Imatinib Mesylate","Animals","Autoimmune Diseases","Benzamides","Disease Models, Animal","Dose-Response Relationship, Drug","Humans","Piperazines","Pyrimidines","Rheumatic Diseases","Protein Kinase Inhibitors"],"keywords":["Imatinib","Imatinib mesylate","Medicine","Tyrosine kinase","Kinase","Pharmacology","Cancer research","Internal medicine","Biology","Receptor"],"sdg_mappings":[{"sdg_number":0,"sdg_label":"Good health and well-being"}],"linked_datasets":[],"clinical_trials":[],"software_tools":[],"database_accessions":[],"source":"live","citation_network_status":"fetched"},"created_at":"2026-08-17T17:41:18.782918Z","pmid":null,"pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}